4DMT to Participate in Chardan’s 9th Annual Genetic Medicines Conference
EMERYVILLE, Calif., Oct. 14, 2025 (GLOBE NEWSWIRE) — 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a…
Molecular Cytogenetics Market worth $1.43 billion in 2030 7.1% CAGR
DELRAY BEACH, Fla., Oct. 14, 2025 /PRNewswire/ —Â The global Molecular Cytogenetics Market , valued at US$0.97 billion in…
Ancient DNA Recovery at Schöningen Site Challenges Long-Held Assumptions on Genetic Preservation
A groundbreaking study by researchers from the University of Tübingen, published in Nature Ecology & Evolution, has revealed…
Myriad Genetics Enhances Foresight® Carrier Screen by Adding F8 and FXN Genes
SALT LAKE CITY, Oct. 14, 2025 (GLOBE NEWSWIRE) — Myriad Genetics, Inc. , (NASDAQ: MYGN), a leader in…
Scientists Unearth 200,000-Year-Old DNA—In a Place It Shouldn’t Have Survived
The study, led by the University of Tübingen and published in Nature Ecology & Evolution, marks a major…
SAGPEK: fast and flexible approach to identify genotypes of Sanger sequencing data | BMC Bioinformatics
Software architecture SAGPEK mainly processes Sanger sequencing results of two kinds of samples: diploids such as humans and…
Mizzou researcher creating a new way to treat genetic disorders
By Brian Consiglio Dunpeng Cai October 14, 2025Contact: Brian Consiglio, consigliob@missouri.eduPhoto by Abbie Lankitus The University of Missouri…
Purespring Therapeutics to Present at Chardan’s 9th Annual Genetic Medicines Conference
Purespring Therapeutics to Present at Chardan’s 9th Annual Genetic Medicines Conference London – 14 October 2025 – Purespring…
Human Genetics Market Share Size to Grow at 10.22% CAGR from 2025
According To Straits Research, the global human genetics market size was valued at USD 31.22 billion in 2024…
Linking Mutations to Cells via Holographic Cytometry
In a groundbreaking advancement at the intersection of cellular biology and optical physics, researchers have unveiled a novel…
New Guides: Understanding Dementia Risk, Genetics, Diagnosis in Communities of Color
Is an Alzheimer’s clinical trial right for you? What does it mean to enroll in an Alzheimer’s clinical…
NHS to screen newborns in England for rare genetic disorder
Hereditary tyrosinaemia type 1 (HT1) affects around one in seven babies a year in the UK. It prevents…